These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2276170)

  • 61. Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer.
    Campani D; Sarnelli R; Fontanini G; Martini L; Cecchetti D; De Luca F; Squartini F
    Ann N Y Acad Sci; 1993 Nov; 698():167-73. PubMed ID: 7904137
    [No Abstract]   [Full Text] [Related]  

  • 62. Malignancies and the skin: looking forward and looking back.
    Ellerin BE
    Clin Dermatol; 2001; 19(3):241-3. PubMed ID: 11479035
    [No Abstract]   [Full Text] [Related]  

  • 63. Influence of long-term limitation of cell proliferation on the cell cycle duration.
    Blokhin AV; Khalyavkin AV
    Cell Prolif; 1995 Aug; 28(8):431-5. PubMed ID: 7548443
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Morphodensitometric analysis of protein kinase C beta(II) expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis.
    Davidson LA; Brown RE; Chang WC; Morris JS; Wang N; Carroll RJ; Turner ND; Lupton JR; Chapkin RS
    Carcinogenesis; 2000 Aug; 21(8):1513-9. PubMed ID: 10910952
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The self-organization of proliferating cellular systems: the basic patterns of interaction, functioning and evolution].
    Dontsov VI
    Fiziol Cheloveka; 1990; 16(4):147-57. PubMed ID: 2227188
    [No Abstract]   [Full Text] [Related]  

  • 66. The histological spectrum of hemangiopericytoma: application of immunohistochemical analysis including proliferative markers to facilitate diagnosis and predict prognosis.
    Middleton LP; Duray PH; Merino MJ
    Hum Pathol; 1998 Jun; 29(6):636-40. PubMed ID: 9635686
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Soft tissue tumor pathology: New diagnostic immunohistochemical markers.
    Doyle LA
    Semin Diagn Pathol; 2015 Sep; 32(5):370-80. PubMed ID: 25726492
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cell proliferation markers in human solid tumors: assessing their impact in clinical oncology.
    Daidone MG; Costa A; Silvestrini R
    Methods Cell Biol; 2001; 64():359-84. PubMed ID: 11070848
    [No Abstract]   [Full Text] [Related]  

  • 69. Cell division: Dodging death at division?
    Brooksbank C
    Nat Rev Mol Cell Biol; 2001 Jan; 2(1):8. PubMed ID: 11413457
    [No Abstract]   [Full Text] [Related]  

  • 70. Demystified ... cell cycle.
    Gillett CE; Barnes DM
    Mol Pathol; 1998 Dec; 51(6):310-6. PubMed ID: 10193511
    [No Abstract]   [Full Text] [Related]  

  • 71. Regulation of E2F: a family of transcription factors involved in proliferation control.
    Black AR; Azizkhan-Clifford J
    Gene; 1999 Sep; 237(2):281-302. PubMed ID: 10521653
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polo-like kinases and the orchestration of cell division.
    Barr FA; Silljé HH; Nigg EA
    Nat Rev Mol Cell Biol; 2004 Jun; 5(6):429-40. PubMed ID: 15173822
    [No Abstract]   [Full Text] [Related]  

  • 73. The cell cycle in steroid hormone regulated proliferation and differentiation.
    Amanatullah DF; Zafonte BT; Pestell RG
    Minerva Endocrinol; 2002 Mar; 27(1):7-20. PubMed ID: 11845110
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Prognostic factors in oncology].
    Siewert JR; Sendler A
    Langenbecks Arch Chir; 1995; 380(4):195-6. PubMed ID: 7674792
    [No Abstract]   [Full Text] [Related]  

  • 75. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
    Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
    Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proliferative activity of acoustic neurilemomas without neurofibromatosis determined by monoclonal antibody MIB 1.
    Aguiar PH; Tatagiba M; Dankoweit-Timpe E; Matthies C; Samii M; Ostertag H
    Acta Neurochir (Wien); 1995; 134(1-2):35-9. PubMed ID: 7668123
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of a restriction point at the M/G1 transition during the ongoing cell cycle.
    Boonstra J
    Adv Enzyme Regul; 2007; 47():208-21. PubMed ID: 17337291
    [No Abstract]   [Full Text] [Related]  

  • 78. Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.
    Camplejohn RS; Brock A; Barnes DM; Gillett C; Raikundalia B; Kreipe H; Parwaresch MR
    Br J Cancer; 1993 Apr; 67(4):657-62. PubMed ID: 7682430
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunohistochemical detection of GLUT1, p63 and phosphorylated histone H1 in head and neck squamous intraepithelial neoplasia: evidence for aberrations in hypoxia-related, cell cycle- and stem-cell-regulatory pathways.
    Burstein DE; Nagi C; Kohtz DS; Lumerman H; Wang BY
    Histopathology; 2006 May; 48(6):708-16. PubMed ID: 16681687
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Distinct Dynamics of Mitotic Transition in B-Cell Lymphoma and Reactive B-Cell Lymphoproliferations Determined by H3S10 Phosphohistone Immunolabeling.
    Méhes G; Hegyi K; Jobanputra R; Beke L; Vereb G; Bedekovics J
    Pathobiology; 2017; 84(5):243-250. PubMed ID: 28715816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.